---
title: "MBX Biosciences (MBX.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/MBX.US/norm.md"
symbol: "MBX.US"
name: "MBX Biosciences"
parent: "https://longbridge.com/zh-HK/quote/MBX.US.md"
datetime: "2026-05-20T18:49:13.402Z"
locales:
  - [en](https://longbridge.com/en/quote/MBX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MBX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MBX.US/norm.md)
---

# MBX Biosciences (MBX.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.5049 | -0.4917 | -0.6321 | -0.5804 | -0.7147 |
| ROE | -23.31% | -23.32% | -28.50% | -34.15% | -38.76% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -23.52M | -22.06M | -21.62M | -19.41M | -23.88M |
| 營業利潤 | -27.27M | -25.80M | -23.93M | -21.80M | -26.53M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 452.70M | 385.14M | 400.08M | 231.52M | 245.93M |
| 權益乘數 | 1.03 | 1.04 | 1.03 | 1.06 | 1.04 |
| 每股凈資產 | 9.20 | 8.22 | 8.67 | 6.53 | 7.04 |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 439.98M | 373.70M | 391.67M | 224.91M | 240.79M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 3.59M | 3.22M | 2.52M | 2.28M | 1.60M |
| 凈債務 | -439.42M | -373.11M | -391.05M | -224.26M | -240.66M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -20.21M | -18.30M | -21.54M | -17.43M | -22.68M |
| 投資現金流 | -97.10M | -129.97M | 17.06M | 25.99M | 3.23M |
| 融資現金流 | 87.44M | 438000.00 | 187.82M | 1.33M | 4000.00 |
| 自由現金流 | -13.59M | -12.69M | -14.31M | -11.86M | -13.58M |
| 現金流充裕率 | -4624.26% | -2307.82% | -5397.49% | -2465.91% | -75593.33% |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | -437000.00 | -793000.00 | -399000.00 | -707000.00 | -30000.00 |